Smoking histories were obtained at ages 11 and 15.4 Blood pressures at age 15 were compared for five groups, defined in terms of their smoking history at age 15: those who had never smoked, had smoked infrequently but not in the past two years, had smoked infrequently in the past two years, had smoked occasionally in the past four weeks, and smoked daily. Analyses of variance and covariance were used.
The table shows means for various systolic blood pressure measures. There was a significant difference among the smoking groups for both unadjusted and adjusted systolic blood pressure at rest and before exercise. After adjustment for height, weight, and sex the difference in blood pressure between the nonsmoking group and the group who smoked daily was 4-3 (95% confidence interval 1-8 to 6-8)mmHg for resting systolic blood pressure and 4-8 (2 1 to 7 5) mm Hg for systolic blood pressure before exercise.
The differences among systolic blood pressures during exercise were not significant, but there were differences for blood pressure after recovery: these were smaller but remained significant after adjustment, suggesting differences in recovery rate among the groups.
The differences in diastolic blood pressure among the groups were not significant. The differences for the blood pressures at age 11 among the 15 year olds who smoked were not significant.
Comment
Explanations suggested for lower interval blood pressure in adult smokers have included lower weight, differences in alcohol consumption, relief of stress by smoking, or a lower "sympathetic tone." Some researchers have even suggested that smokers with hypertension die younger than non-smokers, leaving a population of smokers with lower than average blood pressures.
Our results were similar in direction and magnitude to those found in adult smokers and suggest an effect at least on systolic blood pressure, evident even in young occasional smokers. This effect was not apparent during exercise, suggesting it can be overcome by increased catecholamine release. That the differences had not been evident four years earlier suggests that they were caused by smoking.
Selective mortality does not apply at age 15 and the effect of body size has been adjusted for in the present study. A reduction in sympathetic activity evident in the intervals between smoking seems the only tenable explanation. The mean age of those with brain tumours was 45-1 years, that of the rest of the subjects being 41 7 years. The age adjusted mean cholesterol concentration in those with malignant brain tumours was 6-54 mmol/1 in men and 6-70 mmol/l in women.
The corresponding values in those without brain tumours were both 0-03 mmol/l lower (differences were not significant). In men with non-malignant tumours the mean concentration was 0 31 mmol/l lower and in women with non-malignant tumours it was 0-21 mmol/l higher than in those without tumours. These differences were also not significant. AMorbidity* from brain tumours per million person years by tertiles of serum cholesterol concentration and relative risk* ofbrain tumours between highest and lowest tertiles 
We investigated the possibility of an association between serum cholesterol concentration and the incidence of malignant and non-malignant brain tumours in a large cohort with relatively high serum cholesterol concentrations. No notable association was found. Thus our study does not confirm the findings of previous studies. '4 In the present cohort the mean serum cholesterol concentration was approximately 1-5 mmolIl higher than in the Whitehall population.4 A possible association between the presence of brain tumours and serum cholesterol concentration might, therefore, have been missed in our study if it existed only at low serum cholesterol concentrations, but this is unlikely. The possibility cannot be excluded that the results of the previous case-control studies may be artefactual because an existing brain tumour may have caused a spurious increase in the serum cholesterol concentration. [1] [2] [3] In conclusion, our results, which are based on the largest population reported so far, do not support the conclusion that a high serum cholesterol concentration is a risk factor for brain tumours.
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